Literature DB >> 10839723

Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment.

P W Ewald1, G M Cochran.   

Abstract

Evolutionary considerations implicate infectious causation of atherosclerosis and help to resolve different risk factors as parts of an overall process of disease causation. An evolutionary approach also provides insight for the timing of research efforts to provide better control of pathogen evolution. In particular, evolutionary considerations emphasize the need to understand the transmissibility of Chlamydia pneumoniae from systemic infections in order to control the evolution of antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839723     DOI: 10.1086/315602

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Evolutionary medicine: its scope, interest and potential.

Authors:  Stephen C Stearns
Journal:  Proc Biol Sci       Date:  2012-08-29       Impact factor: 5.349

2.  Mentholation triggers brand-specific shifts in the bacterial microbiota of commercial cigarette products.

Authors:  Leena Malayil; Suhana Chattopadhyay; Prachi Kulkarni; Lauren Hittle; Pamela I Clark; Emmanuel F Mongodin; Amy R Sapkota
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-24       Impact factor: 4.813

3.  Gene/Environment interaction in atherosclerosis: an example of clinical medicine as seen from the evolutionary perspective.

Authors:  Gerhard Mertens
Journal:  Int J Hypertens       Date:  2010-03-25       Impact factor: 2.420

4.  Ten questions for evolutionary studies of disease vulnerability.

Authors:  Randolph M Nesse
Journal:  Evol Appl       Date:  2011-01-17       Impact factor: 5.183

Review 5.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

6.  Disrupted human-pathogen co-evolution: a model for disease.

Authors:  Nuri Kodaman; Rafal S Sobota; Robertino Mera; Barbara G Schneider; Scott M Williams
Journal:  Front Genet       Date:  2014-08-25       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.